CREDIT SUISSE AG/ - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 65 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$107,000
+118.4%
20,292
+36.5%
0.00%
Q3 2020$49,000
-49.0%
14,867
+29.6%
0.00%
Q3 2017$96,000
-13.5%
11,473
-29.8%
0.00%
Q2 2016$111,00016,3350.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 25,445$19,0000.05%
ETF MANAGERS GROUP, LLC 2,258,970$1,654,0000.05%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 116,780$85,0000.02%
GSA CAPITAL PARTNERS LLP 131,036$96,0000.01%
Bernardo Wealth Planning LLC 30,469$20,0000.01%
PCG Wealth Advisors, LLC 15,200$12,0000.00%
Penserra Capital Management LLC 212,298$155,0000.00%
ZEKE CAPITAL ADVISORS, LLC 49,700$36,0000.00%
King Wealth Management Group 16,000$12,0000.00%
Vident Investment Advisory, LLC 105,398$77,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders